ArticleRespiratory medicine case reports2026
Clinicopathological features of primary pulmonary choriocarcinoma in males: A report of two cases and literature review.
Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the clinicopathological characteristics, diagnosis, and treatment strategies of male primary pulmonary choriocarcinoma (PPC) and to enhance understanding of this rare disease. Methods: The clinicopathological data of two male PPC patients were retrospectively analyzed, and literature review was conducted to summarize epidemiological features, pathological mechanisms, and key diagnostic and therapeutic approaches. Case 1: A 14-year-old male presented with recurrent hemoptysis and dyspnea. CT revealed a right hilar mass suggestive of malignancy with multiple bilateral lung metastases. Case 2: A 71-year-old male presented with fatigue. CT identified a left lower hilar mass suspected to be lung cancer. PET-CT revealed a hypermetabolic soft-tissue mass in the left lower lobe. Results: Two cases confirmed as PPC via biopsy. Case 1 died due to severe complications after treatment discontinuation. Case 2 received EMA/CO chemotherapy, which achieved normalized serum β-hCG levels and remained recurrence-free during follow-up 15 months. Literature review identified 68 PPC cases. Pathologically, tumors showed mixed proliferation of syncytiotrophoblasts and cytotrophoblasts with hemorrhagic background. Immunohistochemical markers hCG and CK7 were strongly positive. Treatment primarily involved surgery combined with platinum-based chemotherapy. Median survival was 15 months. Conclusion: Male PPC is extremely rare, particularly in elderly patients, and is often misdiagnosed as lung cancer or metastatic germ cell tumors. Serum hCG testing combined with pathological and immunohistochemical examinations is critical for diagnosis. Early surgery combined with multi-agent chemotherapy improves prognosis. These cases highlight the need to consider PPC in males presenting with solitary pulmonary lesions accompanied by metastases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.